Johnson & Johnson (JNJ) operating KPIs
JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$273.20−2.00 (-0.73%)
Close on Oct 30, 2026Market cap $658.38BP/E 31.7Yield 1.88%
Johnson & Johnson non-GAAP adjusted net earnings ($M) ($M)
Form 8-K EX-99.2 Condensed Consolidated Statement of Earnings & Non-GAAP Reconciliation
Latest, Q3 2026
6,339
Period ended Sep 30, 2026
Change on a year earlier
-6.8%
6,801 in Q3 2025
History
40 quarters
Since Q4 2016
Sources
36
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up non-gaap adjusted net earnings ($m)
- Non-GAAP adjusted net profit margin (% to sales)25.0% · Q3 2026
- Non-GAAP adjusted net earnings growth YoY (%)-6.8% · Q3 2026
- Pre-tax Non-GAAP adjustment — Intangible asset amortization expense ($M)1,240 · Q3 2026
- Pre-tax Non-GAAP adjustment — Litigation-related expense/(gain), net ($M)5,519 · Q3 2026
- Pre-tax Non-GAAP adjustment — Restructuring-related expense ($M)195 · Q3 2026
Cite this data
StockData. (2026). Johnson & Johnson Non-GAAP adjusted net earnings ($M) ($M), quarterly Q4 2016–Q3 2026 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/adj_net_earnings
See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.